Status:
UNKNOWN
The Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in PD
Lead Sponsor:
Inje University
Conditions:
Parkinson's Disease
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Depression is common in Parkinson's disease (PD), but the effective treatment is not established yet. tDCS is a non-invasive brain stimulation to modulate brain function. The tDCS on the depression in...
Eligibility Criteria
Inclusion
- UK Parkinson's disease brain bank criteria
- more than 19 years old
- Able to provide consent for the protocol
- Depression (based on DSM-IV criteria)
Exclusion
- Dementia
- Unpredictable symptom fluctuations
- Contraindication to tDCS (i) irritations, cuts, lesions in the brain (ii) any preexisting unstable medical conditions, or conditions that may increase the risk of stimulation such as uncontrolled epilepsy (iii) history of severe cranial trauma with alteration of the cranial anatomy or metallic intracranial implants (iv) history of seizure
- Subjects without the capacity to give informed consent
- If participation in the study would, in the opinion of the investigators, cause undue risk or stress for reasons such as excessive fatigue, general frailty, or excessive apprehension
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03227783
Start Date
February 1 2019
End Date
December 1 2021
Last Update
October 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inje university, Busan Paik Hospital
Busan, South Korea